These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21894724)

  • 1. [Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study].
    Orsi M; Donato G; Busoni V; Naisberg G; Caruso N
    Acta Gastroenterol Latinoam; 2011 Jun; 41(2):111-8. PubMed ID: 21894724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.
    Bishop J; Furman M; Thomson M
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):50-5. PubMed ID: 17592364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI; Haslam RR; Lundborg P; Davidson GP
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
    Leite LP; Johnston BT; Just RJ; Castell DO
    Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Miner PB; Allgood LD; Grender JM
    Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial.
    Bestebreurtje P; de Koning BAE; Roeleveld N; Knibbe CAJ; Tibboel D; van Groen B; van de Ven CP; Plötz FB; de Wildt SN
    Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):635-643. PubMed ID: 32594305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On-demand treatment of nonerosive reflux disease: omeprazole plus bicarbonate powder versus omeprazole capsules].
    Soifer L; Pedrana R; Parrota M; Gadea O; Naisberg G; Caruso N
    Acta Gastroenterol Latinoam; 2010 Sep; 40(3):198-205. PubMed ID: 21053477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
    Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
    Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance therapy of gastroesophageal reflux disease patients with omeprazole.
    Tepes B; Stabuc B; Kocijancic B; Ivanusa M
    Hepatogastroenterology; 2009; 56(89):67-74. PubMed ID: 19453031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of nasogastric omeprazole suspension in pediatric intensive care patients.
    Haizlip JA; Lugo RA; Cash JJ; Vernon DD
    Pediatr Crit Care Med; 2005 Mar; 6(2):182-7. PubMed ID: 15730606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment.
    Xue Y; Zhou LY; Lin SR
    Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole as a diagnostic tool in gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Jansen EH; Tuynman HA; Schrijver M; Dieleman LA; Meuwissen SG
    Am J Gastroenterol; 1997 Nov; 92(11):1997-2000. PubMed ID: 9362179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Omeprazole of limited value in crying babies].
    Blokpoel RG; Broos N; de Jong-van den Berg LT; de Vries TW
    Ned Tijdschr Geneeskd; 2010; 154():A1850. PubMed ID: 20719016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric therapy for gastroesophageal reflux disease.
    Schindlbeck NE; Klauser AG; Voderholzer WA; Müller-Lissner SA
    Arch Intern Med; 1995 Sep; 155(16):1808-12. PubMed ID: 7654116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.